DUKE UNIVERSITY

• DELOITTE CONSULTING LLP

  UEI CKV2L9GZKJK3

  $1.7M

  Subcontractor to this prime · 1 sub-award · latest Aug 6, 2024

  • Centers for Medicare and Medicaid Services
  • “REGIONAL LEARNING SYSTEM CONTRACT FOR THE CENTER FOR MEDICARE & MEDICAID INNOVATION (CMMI) - BASE YEAR”
• BATTELLE MEMORIAL INSTITUTE

  UEI ZFX8JGFQ89F4

  $816.1K

  Subcontractor to this prime · 1 sub-award · latest Sep 27, 2024

  • National Institutes of Health
  • “STUDY START UP , DATA DELIVERY”
• TRIAD NATIONAL SECURITY, LLC

  UEI X7WUS5LRBQU3

  $714K

  Subcontractor to this prime · 2 sub-awards · latest Nov 17, 2025

  • Department of Energy
  • “DUKE UNIVERSITY-STAND ALONE-ITEM LEVEL-R AND D”
  • “DUKE UNIVERSITY-STAND ALONE-ITEM LEVEL-CONTINGENT LABOR AND HUMAN RESOURCE SERVICES”
• BOOZ ALLEN HAMILTON INC

  UEI JCBMLGPE6Z71

  $198.5K

  Subcontractor to this prime · 1 sub-award · latest Apr 16, 2026

  • Federal Acquisition Service
  • “EDUCATION, RESEARCH, AND MEDICAL CARE”
• THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO

  UEI C3KXNLTAAY98 · not in the directory yet

  $101K

  Subcontractor to this prime · 2 sub-awards · latest Jul 30, 2026

  • National Institutes of Health
  • “DUKE CLINICAL RESEARCH INSTITUTE (DCRI) WILL OVERSEE AND FACILITATE THE COMPLETION OF THE BASELINE ECHOCARDIOGRAM EXAM FOR RURAL THROUGH ALL KENTUCKY COUNTIES AS PART OF TASK AREA B1. DCRI WILL OVERSEE THE ACQUISITION OF ARTIFICIAL INTELLIGENCE-GUIDED ECHOCARDIOGRAMS (AI-ECHOS) ON THE MOBILE EXAMINATION UNIT (MEU), WHICH WILL BE PERFORMED USING A FUNCTIONING PORTABLE ECHO MACHINE PROVIDED BY THE MANUFACTURER (CAPTION HEALTH OR GE ULTRASOUND) THROUGH DCRI. DCRI WILL OVERSEE TRANSMISSION AND STORAGE OF DIGITAL IMAGES WHICH WILL BE PROVIDED TO BIODATA CATALYST AT THE COMPLETION OF TASK AREA B1. IMAGES WILL BE PRIMARY READ AND MD OVER-READ IN THE DCRI IMAGING CORE LABORATORY FOR FINDINGS INCLUDING, BUT NOT LIMITED TO, RIGHT AND LEFT ATRIAL AND VENTRICULAR STRUCTURE AND FUNCTION; VALVULAR HEART DISEASE (WITH FOCUSED COLOR DOPPLER IMAGES); PERICARDIAL DISEASE AND AORTIC ABNORMALITIES. IMAGE READS WILL CORRESPOND TO THE READING APPROACH EMPLOYED FOR COUNTIES IN AL, MS AND LA TO DATE THROUGH THE RURAL ECHO ANCILLARY STUDY, AND DATA WILL BE ELECTRONICALLY TRANSMITTED TO THE STATISTICAL AND DATA COORDINATING CENTER (SDCC). QUALITY ASSURANCE FOR IMAGE ACQUISITION WILL OCCUR THROUGH REMOTE QUARTERLY READS WITH MEU STAFF. AS HAS BEEN PERFORMED TO DATE, ECHO IMAGES WILL BE READ ON AN EXPEDITED BASIS FOR A SELECT SET OF ‘CRITICAL ALERT’ FINDINGS, AND TEXT WILL BE PROVIDED AFTER IMAGES HAVE BEEN OVER-READ BY LEVEL 3 PHYSICIAN ECHOCARDIOGRAPHERS FOR ‘RETURN OF RESULTS’. DCRI WILL CONTINUE TO ENGAGE WITH AND SUPPORT ANCILLARY STUDIES THAT USE ECHOCARDIOGRAPHIC DATA.”
  • “DUKE CLINICAL RESEARCH INSTITUTE (DCRI) WILL OVERSEE AND FACILITATE THE COMPLETION OF THE BASELINE ECHOCARDIOGRAM EXAM FOR RURAL THROUGH ALL KENTUCKY COUNTIES AS PART OF TASK AREA B1. DCRI WILL OVERSEE THE ACQUISITION OF ARTIFICIAL INTELLIGENCE-GUIDED ECHOCARDIOGRAMS (AI-ECHOS) ON THE MOBILE EXAMINATION UNIT (MEU), WHICH WILL BE PERFORMED USING A FUNCTIONING PORTABLE ECHO MACHINE PROVIDED BY THE MANUFACTURER (CAPTION HEALTH OR GE ULTRASOUND) THROUGH DCRI. DCRI WILL OVERSEE TRANSMISSION AND STORAGE OF DIGITAL IMAGES WHICH WILL BE PROVIDED TO BIODATA CATALYST AT THE COMPLETION OF TASK AREA B1. IMAGES WILL BE PRIMARY READ AND MD OVER-READ IN THE DCRI IMAGING CORE LABORATORY FOR FINDINGS INCLUDING, BUT NOT LIMITED TO, RIGHT AND LEFT ATRIAL AND VENTRICULAR STRUCTURE AND FUNCTION; VALVULAR HEART DISEASE (WITH FOCUSED COLOR DOPPLER IMAGES); PERICARDIAL DISEASE AND AORTIC ABNORMALITIES. IMAGE READS WILL CORRESPOND TO THE READING APPROACH EMPLOYED FOR COUNTIES IN AL, MS AND LA TO DATE THROUGH THE RURAL ECHO ANCILLARY STUDY, AND DATA WILL BE ELECTRONICALLY TRANSMITTED TO THE STATISTICAL AND DATA COORDINATING CENTER (SDCC). QUALITY ASSURANCE FOR IMAGE ACQUISITION WILL OCCUR THROUGH REMOTE QUARTERLY READS WITH MEU STAFF. AS HAS BEEN PERFORMED TO DATE, ECHO IMAGES WILL BE READ ON AN EXPEDITED BASIS FOR A SELECT SET OF ‘CRITICAL ALERT’ FINDINGS, AND TEXT WILL BE PROVIDED AFTER IMAGES HAVE BEEN OVER-READ BY LEVEL 3 PHYSICIAN ECHOCARDIOGRAPHERS FOR ‘RETURN OF RESULTS’. DCRI WILL CONTINUE TO ENGAGE WITH AND SUPPORT ANCILLARY STUDIES THAT USE ECHOCARDIOGRAPHIC DATA. FOR TASK AREA A, DCRI WILL ACTIVELY PARTICIPATE THROUGHOUT THE DESIGN, IMPLEMENTATION AND EVALUATION PHASES THROUGH PARTICIPATION IN COMMITTEES, RESEARCH MEETINGS, DATA ANALYSIS AND MANUSCRIPT PREPARATION.”
• HONEYWELL FEDERAL MANUFACTURING & TECHNOLOGIES, LLC

  UEI DMEGBYTVBQS5

  $99.8K

  Subcontractor to this prime · 1 sub-award · latest Mar 3, 2026

  • Department of Energy
  • “R&D”
• MODERN TECHNOLOGY SOLUTIONS, INC.

  UEI R8KMUKAJRKJ6

  $52.9K

  Subcontractor to this prime · 1 sub-award · latest Aug 31, 2026

  • Federal Acquisition Service
  • “TRAINING FOR ARCWERX EMPLOYEES.”
• UNIVERSITY OF OKLAHOMA

  UEI GY8NMUZQXVS7 · not in the directory yet

  $33.5K

  Subcontractor to this prime · 1 sub-award · latest Jun 1, 2026

  • National Institutes of Health
  • “TASK A THROUGH A SUBCONTRACT ARRANGEMENT BETWEEN THE DEPARTMENT OF POPULATION HEALTH SCIENCES IN THE DUKE UNIVERSITY SCHOOL OF MEDICINE AND THE UNIVERSITY OF OKLAHOMA COORDINATING CENTER, DUKE UNIVERSITY WILL (1) PROVIDE GUIDANCE ON THE ACQUISITION OF MEDICARE CLAIMS DATA FOR STRONG HEART STUDY PARTICIPANTS; AND (2) PROVIDE GUIDANCE ON THE USAGE OF MEDICARE CLAIMS TO STUDY CARDIOVASCULAR DISEASE AMONG AMERICAN INDIANS. GUIDANCE ON ACQUISITION OF MEDICARE CLAIMS DATA • REVIEW AND PROVIDE GUIDANCE ON APPLICATION MATERIALS REQUIRED SUBMITTED TO RESDAC FOR A NEW STUDY DATA USE AGREEMENT (DUA) TO THE CENTERS FOR MEDICARE & MEDICAID SERVICES (CMS) FOR THE ACQUISITION OF MEDICARE DATA FOR STRONG HEART STUDY (SHS) PARTICIPANTS. • FOLLOWING EXECUTION OF THE NEW STUDY DUA: REVIEW AND PROVIDE GUIDANCE ON THE SUBMISSION OF APPLICATION MATERIALS REQUIRED TO ANNUALLY REFRESH THE CLAIMS DATA FOR SHS PARTICIPANTS. • PROVIDE GUIDANCE ON HOW TO RENEW THE DUA, NOTIFY CMS OF PROJECT STAFF CHANGES AND/OR CHANGES TO THE CMS DUA STUDY SCOPE. GUIDANCE ON USAGE OF MEDICARE CLAIMS • PROVIDE GUIDANCE ON BEST PRACTICES WHEN ANALYZING MEDICARE DATA. • PROVIDE INSIGHT ON THE STRENGTHS AND WEAKNESSES OF MEDICARE DATA TO ADDRESS SPECIFIC RESEARCH QUESTIONS. • PROVIDE GUIDANCE ON PROGRAMMING AND DATA MANAGEMENT. • HOST WEBINARS RELATED TO THE USE OF MEDICARE CLAIMS.”

• UNIVERSITY OF CALIFORNIA, SANTA BARBARA

  UEI G9QBQDH39DF4 · not in the directory yet

  $746.3K

  Subcontracted by this company · 1 sub-award · latest Jul 25, 2024

  • Department of the Army
  • “WE WILL COLLABORATE WITH PARTNERS AT DUKE UNIVERSITY ON A RESEARCH PROJECT UNDER THE STRATEGIC ENVIRONMENTAL RESEARCH AND DEVELOPMENT PROGRAM€„¢S (SERDP) RESOURCE CONSERVATION AND RESILIENCY PROGRAM. THE PURPOSE OF THIS WORK IS TO DEVELOP, DEMONSTRATE, AND DELIVER A COMPUTATIONAL ASSESSMENT TOOL CALLED MOTIVES (MODEL-BASED TRACKING AND INTEGRATED VALUATION OF ECOSYSTEM SERVICES) THAT CAN BE USED AT ANY DEPARTMENT OF DEFENSE FACILITY TO DOCUMENT, PREDICT, AND ENHANCE THE DELIVERY OF VALUABLE ECOSYSTEM SERVICES WHILE ENSURING THE CONTINUED AVAILABILITY OF NECESSARY TRAINING AND TESTING CONDITIONS. BUILDING ON A LIMITED SCOPE PROJECT THAT APPLIED MOTIVES TO EGLIN AIR FORCE BASE, THIS NEXT PHASE OF THE PROJECT WILL APPLY THE MODEL TO THREE ADDITIONAL BASES.”
• INIMMUNE CORP

  UEI EF8AMXMGG8W5

  $613.6K

  Subcontracted by this company · 1 sub-award · latest Jan 29, 2026

  • National Institutes of Health
  • “2.1 ACTIVITY (RA-2A): THE CONTRACTOR SHALL PROVIDE THE EQUIPMENT, FACILITIES, AND OTHER RESOURCES REQUIRED TO DEVELOP AND MANUFACTURE FORMULATIONS FOR THE THREE TEST ADJUVANTS TO SUPPORT STUDIES DESCRIBED IN THIS PROPOSAL. (INIMMUNE)€¢ TASK 2.1.1: SUPPLY INI-4001 AND INI-2001 IN AQUEOUS FORMULATION FOR IN VITRO ASSAYS (EVANS LAB, MONTH 3)€¢ TASK 2.1.2: SUPPLY INI-4001 AND INI-2001 IN OPTIMAL FORMULATION FOR IN VITRO AND IN VIVO STUDIES (EVANS LAB, CONTINUOUSLY)€¢ TASK 2.1.3: FORMULATION COMPATIBILITY TEST FOR CPG, INI-4001 AND INI-2004 (BURKHART LAB, MONTH 9) €¢ TASK 2.1.4: FORMULATION TRANSWELL ASSAY FOR CPG, INI-4001 AND INI-2004 (BURKHART LAB, MONTH 2) 2.2 ACTIVITY (RA-2B): THE CONTRACTOR SHALL PROVIDE THE EQUIPMENT, FACILITIES, AND OTHER RESOURCES REQUIRED TO COMPARE THE IMMUNOGENICITY OF VARIOUS ADJUVANT FORMULATIONS FOR SUBLINGUAL IMMUNIZATION. (INIMMUNE)€¢ TASK 2.2.1: IN VIVO IMMUNOGENICITY WITH THREE FORMULATIONS (EVANS LAB, MONTH 24) O ELISAS FOR SERUM, FECAL AND SALIVA ANTIBODY RESPONSES€¢ TASK 2.2.2: IN VIVO IMMUNOGENICITY DOSE RESPONSE WITH OPTIMAL FORMULATION FOR EACH TEST ADJUVANT. (EVANS LAB, MONTH 24) O ELISAS FOR SERUM, FECAL AND SALIVA ANTIBODY RESPONSES”
• UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL

  UEI D3LHU66KBLD5

  $600.8K

  Subcontracted by this company · 1 sub-award · latest Feb 14, 2025

  • National Institutes of Health
  • “THE OVERALL GOAL OF THIS PROJECT IS TO EVALUATE VARIOUS ADJUVANTS AND COMBINATIONS OF THESE ADJUVANTS FOR USE IN MUCOSAL IMMUNOTHERAPY FOR PEANUT ALLERGY. DR. KULIS AND HIS TEAM AT UNC CHAPEL HILL WILL PERFORM IN VIVO MOUSE STUDIES, ASSAY HUMAN PERIPHERAL BLOOD CELLS, AND QUANTIFY IMMUNOLOGIC RESPONSES TO ADJUVANTS AND PEANUT FROM BOTH MOUSE AND HUMAN BLOOD. SPECIFICALLY, WE WILL EVALUATE SIX ADJUVANT FORMULATIONS IN CELL CULTURE ASSAYS WITH HUMAN T AND B CELLS FROM BLOOD, PRIMARILY INVESTIGATING CYTOKINE RESPONSES AND THEN SENDING CELLS FROM THESE EXPERIMENTS TO DUKE FOR OMICS EXPERIMENTS. FOR THE MOUSE STUDIES, WE WILL EVALUATE THE SAME SIX ADJUVANTS PLUS PEANUT BY ADDING THE ADJUVANTS TO SPLEEN AND LYMPH NODE CELLS IN CULTURE. WE WILL ALSO ADMINISTER THE ADJUVANTS AND PEANUT BY THE SUBLINGUAL ROUTE TO LIVE MICE THAT ARE EITHER NOT SENSITIZED TO PEANUT OR IN MICE THAT HAVE AN ESTABLISHED PEANUT ALLERGY. WE WILL PERFORM THESE EXPERIMENTS AT UNC, AND ALSO SAVE VARIOUS SAMPLES (SPLEEN, LYMPH NODE, SERUM, SALIVA, AND FECAL PELLETS) TO SHIP TO DUKE FOR OMICS STUDIES. ULTIMATELY, THE SIX ADJUVANTS WILL BE EVALUATED FOR THEIR SAFETY AND EFFICACY IN THE PEANUT ALLERGIC MICE. SINCE THIS PROJECT INVOLVES TEAM MEMBERS AT DUKE AND INIMMUNE, WE WILL ALSO PARTICIPATE IN BIWEEKLY MEETINGS TO DISCUSS EXPERIMENTAL DESIGN, PROGRESS, AND DATA ANALYSIS. TWO TEAM MEMBERS FROM UNC (DR. KULIS AND DR. SMEEKENS) WILL ATTEND ANNUAL MEETINGS AT NIH IN BETHESDA, MD. WE ANTICIPATE PUBLISHING SEVERAL MANUSCRIPTS BASED ON THE WORK DONE AT UNC IN COLLABORATION WITH DUKE AND INIMMUNE, WHICH THE UNC TEAM WILL BE HEAVILY INVOLVED IN WRITING.”
• OPANS LLC

  UEI CA3FVY63T5L8

  $572.3K

  Subcontracted by this company · 1 sub-award · latest Dec 23, 2025

  • National Institutes of Health
  • “DCRI #7877 CLINICAL PHARMACOKINETICS AND SAFETY TRIALS IN DOWN SYNDROME”
• INSTITUTE FOR MEDICAL RESEARCH INC

  UEI L7L5FCBEFY41

  $63.7K

  Subcontracted by this company · 1 sub-award · latest Aug 13, 2026

  • Defense Health Agency
  • “TO CONDUCT A PHASE II RANDOMIZED CONTROLLED TRIAL WITH A NOVEL NEUROSTEROID INTERVENTION (PREGNENOLONE) TO MAXIMALLY WELL-TOLERATED DOSING IN OEF/OIF/OND VETERANS WITH A HISTORY OF CHRONIC TBI (APPROXIMATELY 54 PARTICIPANTS/GROUP, 108 TOTAL) TO DETERMINE IF PREGNENOLONE IMPROVES PSYCHOLOGICAL HEALTH (PRIMARY ENDPOINT, BSI), IN ADDITION TO FUNCTIONAL OUTCOME (SF-36), COGNITION (WAIS-IV, COLOR-WORD INTERFERENCE TEST [STROOP]), PTSD SYMPTOMS (PCL5), DEPRESSION SYMPTOMS (BDI-II), AND PAIN SYMPTOMS (BPI) [SECONDARY ENDPOINTS] COMPARED TO PLACEBO.”

Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.

No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).

The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.